Navigation Links
Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
Date:9/19/2013

analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-17/PFE]

--

GlaxoSmithKline plc Research Report

On September 16, 2013, GlaxoSmithKline plc (GlaxoSmithKline) announced that the US FDA has granted Priority Review designation to the Company's supplemental New Drug Applications (sNDAs) for combined use of Tafinlar (dabrafenib) and Mekinist (trametinib) for the treatment of adult patients with unresectable or metastatic melanoma with a BRAF V600 E and V600 K mutation. GlaxoSmithKline informed that the FDA has assigned a Prescription Drug User Fee Act (PDUFA) target date of January 8, 2014 for the Mekinist supplement, and January 9, 2014 for the Tafinlar supplement. The Full Research Report on GlaxoSmithKline plc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.investorsreports.com/report/2013-09-17/GSK]

--

Sanofi SA Research Report

On September 17, 2013, Sanofi SA (Sanofi) and its subsidiary Genzyme announced that the European Commission has granted marketing authorization for Lemtrada. Genzyme informed that it plans to begin launching Lemtrada and the previously approved Aubagio in the EU soon. "The approvals of Lemtrada and Aubagio in the European Union represent an important milestone for Genzyme and demonstrate our focus on scientific innovation and commitment to multiple sclerosis patients. This is particularly exciting as the EU approval is the first for Lemtrada globally," said David Meeker, M.D., President and CEO of Genzyme. "The Lemtrada clinical trial data support its potential to meaningfully address disability in active RRMS patients, while Aubagio's efficacy, safety and convenient dosing may provid
'/>"/>

SOURCE Investors' Reports
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
2. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
3. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
4. AtheroNova Signs Agreement for Development of Clinical Trial Supplies
5. Southern Research Signs Agreement with Apath, LLC to Conduct Preclinical Studies with Virus-Based HCV Screenings
6. Varian Medical Systems and Siemens Healthcare Announce Global Collaboration to Advance Clinical Capabilities and Offerings in Radiotherapy and Radiosurgery
7. New Clinical Endocrinology Guidelines Support Lp-PLA2 Measurement For Risk Assessment of Coronary Artery Disease
8. First Patient Treated in U.S. Clinical Study of Cohera Medicals TissuGlu® Surgical Adhesive
9. Michael J. Fox Foundation-Funded Study Identifies Best Dyskinesia Clinical Rating Scale
10. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
11. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 3, 2015 /CNW/ - ChipCare Corporation, a University of ... for HIV and other infectious and non-communicable diseases ... to bring its first-generation product to market while ... (Photo: http://photos.prnewswire.com/prnh/20150303/179107 ) ... simple, accurate and affordable diagnostic tests makes it ...
(Date:3/3/2015)... -- Tru-D SmartUVC will exhibit the cutting-edge UV disinfection ... Surgical Conference and Expo 2015 in ... Week March 7 through 11. AORN provides perioperative ... professional development. Photo - ... Tru-D SmartUVC,s UV light disinfection ...
(Date:3/3/2015)...  Delcath Systems, Inc. (NASDAQ: DCTH ... focused on oncology with an emphasis on the ... that the results from its Phase 3 clinical ... submitted for publication in a leading peer-reviewed medical ... Injection for use with the Delcath Hepatic Delivery ...
Breaking Medicine Technology:ChipCare Closes Oversubscribed $5 Million Series A Financing 2ChipCare Closes Oversubscribed $5 Million Series A Financing 3Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 2Tru-D SmartUVC to Exhibit Most Effective UV Disinfection Robot at AORN Surgical Conference and Expo 2015 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 2Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 3Delcath Announces Submission Of Phase 3 Trial Results For Publication In A Leading Peer-Reviewed Medical Journal 4
... 18 Telik, Inc.,(Nasdaq: TELK ) announced ... small molecule kinase inhibitors will be presented at ... in,San Francisco. The presentation, "In Vitro and Vivo ... VEGFR2" (Abstract # C206) will be,on Thursday, October ...
... MRSA, WASHINGTON, Oct. 18 Building on the ... infection by 50 percent,the Department of Veterans Affairs (VA) ... of its 153 hospitals., In addition to emphasizing ... special precautions, VA facilities monitor,all incoming patients on key ...
Cached Medicine Technology:VA National Campaign Takes Aim at Resistant Staph Infections 2
(Date:3/3/2015)... March 03, 2015 In March, 1% ... networks, will kick off a new campaign, “Know Your Source,” ... businesses, nonprofits, and ambassadors in their quest for ingredient awareness ... with several of its members and partners, including King Arthur ... Once network, to raise awareness for food as an environmental ...
(Date:3/3/2015)... 2015 While it is clear that ... why young Canadian drivers are signing up to UBI ... proposition to be enticed. Due to current regulations, the ... stripped-back form. Its full capability is starting to ... predictive maintenance, emergency breakdown services are at the top ...
(Date:3/3/2015)... MD (PRWEB) March 03, 2015 Today ... Association (ASHA) is using the occasion to applaud and ... campaign by the World Health Organization (WHO) for stemming ... campaign aims to encourage young people to practice safe ... audio technology, attending concerts or sporting events, or engaging ...
(Date:3/3/2015)... Calif. (PRWEB) March 03, 2015 The Calistoga ... area, “Mudder of All Weekends,” taking place Friday, March 27, ... scavenger hunt, Pretty Muddy 5K fun run, restaurant and bar ... event is open to women, ages 14 and older. , ... are getting in on the action by offering Mudder ...
(Date:3/3/2015)... MI (PRWEB) March 03, 2015 In ... News Morning Edition, science correspondent Shankar Vedantam shared ... of Pennsylvania about the drastic decrease in hand-hygiene compliance that ... suggested that the problem could be solved in part by ... hand hygiene when they enter and exit a patient’s room. ...
Breaking Medicine News(10 mins):Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:TU-Automotive: Wawanesa Insurance to Discuss How UBI Can Produce Happy, Loyal Customers 2Health News:ASHA Applauds Launch of New WHO Campaign 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 2Health News:Visit Calistoga Hosts Mudder of All Weekends Girlfriend Getaway Event 3Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 2Health News:BIOVIGIL Hygiene Technologies Answers Call for Hand Hygiene Alerts on Badges 3
... Rapid Advances in Nation,s 4th Leading Cancer Killer, ... Foundation for,Pancreatic Cancer Research, the largest private foundation ... its,Year 2009 Request For Proposals (RFP) to identify ... of cancer deaths in the United,States., The ...
... June 21, 2008, New Alternatives,for Children (NAC), a New ... disabilities and/or chronic illnesses, will,hold its 3rd Annual NAC ... 12:00 noon to 3:30 pm rain or shine., ... family members,are expected to participate in the 2008 NAC ...
... to fight tumors. Often, tumors have more than one way ... Now, in a new study, University of Missouri researchers have ... cells, by combining a small molecular drug that targets tumor ... blood vessels. , In 50 percent of breast cancer cases, ...
... June 18 Movement Against Cancer,(MAC), cancer patient advocacy ... urge people in Russia to undergo early screening,tests and ... prostate cancer and cervical cancer -- the types of ... of the most serious problems with cancer treatment in ...
... who dropped most pounds went off diabetes meds ... (HealthDay News) -- Weight loss plays a major role ... say Duke University Medical Center researchers. , Previous ... re-routes how food is sent from the stomach to ...
... more than two years ago at Children,s Hospital ... between caregivers and patients and improved patient and ... found. , Children,s Hospital became the first pediatric ... King Foundation to launch a patient safety initiative ...
Cached Medicine News:Health News:Lustgarten Foundation Announces 2009 Request for Proposals (RFP) 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 2Health News:2008 NAC Kids Olympics Celebrates the Achievements and Persevering Spirits of Hundreds of Children with Disabilities and Chronic Illnesses on Saturday, June 21, 2008 at Riverbank State Park 3Health News:New cancer treatment targets both tumor cells and blood vessels 2Health News:Movement Against Cancer Launches An All-Russia Cancer Awareness Campaign to Promote Early Screening and Cancer Detection Programs in Russia's Regions 2Health News:Weight Loss After Gastric Bypass Is Key to Easing Diabetes 2Health News:Study finds Children's Hospital patient safety program improves caregiver/family communications 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: